重症监护病房急性胰腺炎患者院内早期死亡预测模型的建立与评价
该回顾性队列研究利用MIMIC-III数据库中285例入住ICU的急性胰腺炎患者数据,比较死亡组(29例)与存活组(256例)的临床资料,采用多因素Logistic回归筛选院内死亡的独立预测因素并建立预测模型与列线图。结果显示年龄、WBC、TBil、BUN、RDW为独立危险因素,模型预测院内死亡的AUC为0.870(95%CI 0.794-0.946),灵敏度86.2%、特异度78.5%,优于SAPS III评分(AUC 0.831,95%CI 0.754-0.907)。列线图校准曲线与标准曲线接近(χ²=6.986,P=0.538)。作者认为该模型可较准确预测急性胰腺炎患者死亡概率,为预后判断和临床治疗提供依据。
要点
- 年龄、WBC、TBil、BUN、RDW是ICU急性胰腺炎患者院内死亡的独立危险因素(多因素Logistic回归,OR分别为1.038、1.103、1.247、1.034、1.344)。
- 基于上述5项指标构建的Logistic回归模型预测院内死亡AUC为0.870(95%CI 0.794-0.946),灵敏度86.2%、特异度78.5%。
- 该模型预测效能优于SAPS III评分(AUC 0.831,95%CI 0.754-0.907;灵敏度82.8%、特异度75.4%)。
- 列线图模型校准曲线与标准曲线接近,Hosmer-Lemeshow拟合优度检验χ²=6.986,P=0.538。
- 死亡组年龄(70±17岁 vs 58±16岁)、WBC、TBil、SCr、BUN、RDW、充血性心力衰竭比例(34.5% vs 14.8%)及SAPS III评分[66(52,90)vs 39(30,48)]均高于存活组,均P<0.05。
适用人群与场景
- 入住ICU的急性胰腺炎患者,数据来自MIMIC-III数据库,共285例(院内死亡29例,存活256例)。
研究设计与关键结果
- 研究类型:回顾性队列研究,使用MIMIC-III数据库数据,纳入285例入住ICU的急性胰腺炎患者,院内死亡29例、存活256例。
- 单因素分析:死亡组年龄(70±17岁 vs 58±16岁)、WBC[18.5(13.9,24.3)×10⁹/L vs 13.2(9.3,17.9)×10⁹/L]、TBil[29.1(15.4,66.7)μmol/L vs 16.2(10.3,29.1)μmol/L]、SCr[114.9(88.4,300.6)μmol/L vs 79.6(53.0,114.9)μmol/L]、BUN[13.9(9.3,17.8)mmol/L vs 6.1(3.7,9.6)mmol/L]、RDW[0.152(0.141,0.165) vs 0.141(0.134,0.150)]、充血性心力衰竭比例(34.5% vs 14.8%)及SAPS III评分[66(52,90) vs 39(30,48)]均高于存活组,均P<0.05。
- 多因素Logistic回归:年龄(OR=1.038,95%CI 1.005-1.073)、WBC(OR=1.103,95%CI 1.038-1.172)、TBil(OR=1.247,95%CI 1.066-1.459)、BUN(OR=1.034,95%CI 1.014-1.055)、RDW(OR=1.344,95%CI 1.024-1.764)为院内死亡的独立危险因素。
- 预测模型:Logit(P)=0.037×年龄+0.098×WBC+0.221×TBil+0.033×BUN+0.296×RDW-12.133。
- 模型预测院内死亡的AUC为0.870(95%CI 0.794-0.946),灵敏度86.2%,特异度78.5%;SAPS III评分AUC为0.831(95%CI 0.754-0.907),灵敏度82.8%,特异度75.4%。
- 列线图模型校准曲线与标准曲线非常接近,Hosmer-Lemeshow拟合优度检验χ²=6.986,P=0.538。
证据类型、等级与局限
- 证据类型:回顾性队列研究(基于MIMIC-III数据库)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,基于年龄、WBC、TBil、BUN、RDW构建的死亡预测Logistic回归模型和列线图模型具有良好判别能力和较高准确性,可较准确预测急性胰腺炎患者死亡概率,为预后判断和临床治疗提供依据。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the death risk prediction factors of acute pancreatitis (AP) patients in intensive care unit (ICU), and to establish a death prediction model and evaluate its efficacy.
METHODS: A retrospective cohort study was conducted using the data in the Medical Information Mart for Intensive Care-III (MIMIC-III). The clinical data of 285 AP patients admitted to the ICU in the database were collected, including age, gender, blood routine and blood biochemical indicators, comorbidities, simplified acute physiology score III (SAPS III) and hospital prognosis. By using univariate analysis, the differences in the clinical data of the patients were compared between the two groups. Binary multivariate Logistic regression analysis was used to screen out independent predictors of in-hospital death in AP patients. A death prediction model was established, and the nomogram was drawn. The receiver operator characteristic curve (ROC curve) was plotted, and the area under the ROC curve (AUC) was used to test the discrimination of the prediction model. In addition, the prediction model was compared with the SAPS III score in predicting in-hospital death. The calibration ability of the prediction model was evaluated by the Hosmer-Lemeshow goodness of fit test, and a calibration map was drawn to show the calibration degree of the prediction model.
RESULTS: Among 285 patients with AP, 29 patients died in the hospital and 256 patients survived. Univariate analysis showed that the patients in the death group were older than those in the survival group (years old: 70±17 vs. 58±16), and had higher white blood cell count (WBC), total bilirubin (TBil), serum creatinine (SCr), blood urea nitrogen (BUN), red blood cell volume distribution width (RDW), proportion of congestive heart failure and SAPS III score [WBC (×109/L): 18.5 (13.9, 24.3) vs. 13.2 (9.3, 17.9), TBil (μmol/L): 29.1 (15.4, 66.7) vs. 16.2 (10.3, 29.1), SCr (μmol/L): 114.9 (88.4, 300.6) vs. 79.6 (53.0, 114.9), BUN (mmol/L): 13.9 (9.3, 17.8) vs. 6.1 (3.7, 9.6), RDW: 0.152 (0.141, 0.165) vs. 0.141 (0.134, 0.150), congestive heart failure: 34.5% vs. 14.8%, SAPS III score: 66 (52, 90) vs. 39 (30, 48), all P < 0.05]. Multivariate Logistic regression analysis showed that age [odds ratio (OR) = 1.038, 95% confidence interval (95%CI) was 1.005-1.073], WBC (OR = 1.103, 95%CI was 1.038-1.172), TBil (OR = 1.247, 95%CI was 1.066-1.459), BUN (OR = 1.034, 95%CI was 1.014-1.055) and RDW (OR = 1.344, 95%CI was 1.024-1.764) were independent risk predictors of in-hospital death in patients with AP. Logistic regression model was established: Logit(P) = 0.037×age+0.098×WBC+0.221×TBil+0.033×BUN+0.296×RDW-12.133. ROC curve analysis showed that the AUC of the Logistic regression model for predicting the in-hospital death of patients with AP was 0.870 (95%CI was 0.794-0.946), the sensitivity was 86.2%, and the specificity was 78.5%, indicating that the model had good predictive performance, and it was superior to the SAPS III score [AUC was 0.831 (95%CI was 0.754-0.907), the sensitivity was 82.8%, and the specificity was 75.4%]. A nomogram model was established based on the result of multivariate Logistic regression analysis. The calibration map showed that the calibration curve of the nomogram model was very close to the standard curve, with the goodness of fit test: χ2 = 6.986, P = 0.538, indicating that the consistency between the predicted death risk of the nomogram model and the actual occurrence risk was relatively high.
CONCLUSIONS: The older the AP patient is, the higher the WBC, TBil, BUN, and RDW, and the greater the risk of hospital death. The death prediction Logistic regression model and nomogram model constructed based on the above indicators have good discrimination ability and high accuracy for high-risk patients with hospital death, which can accurately predict the probability of death in AP patients and provide a basis for prognosis judgment and clinical treatment of AP patients.
参考来源
- Yu L, Zhou X, Li Y, et al. [Establishment and evaluation of early in-hospital death prediction model for patients with acute pancreatitis in intensive care unit]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 37593868. doi:10.3760/cma.j.cn121430-20220713-00660
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。